Australis Capital Inc.
OTC: AUSAF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Terrance R. Booth
- Employees
- 18
- Headquarters
- Las Vegas, United States
- IPO year
- 2018
- Market cap
- $5.6K
- Website
- https://www.ausa-corp.com
Loading AUSAF…
Loading profile data…Frequently asked questions about AUSAF
What does Australis Capital Inc. (AUSAF) do?
Australis Capital Inc. functions as a cannabis enterprise, actively pursuing both cannabis and horticultural ventures. These projects span a broad international landscape, encompassing the United States, Canada, Denmark, Finland, Iceland, Germany, the Netherlands, Bahrain, the United Arab Emirates, Southeast Asia, Australia, and numerous other g...
Where does AUSAF trade?
Australis Capital Inc. (AUSAF) trades on the Other OTC.
What sector is AUSAF in?
Australis Capital Inc. (AUSAF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Australis Capital Inc.?
Terrance R. Booth is the chief executive officer of Australis Capital Inc. (AUSAF).
Where is Australis Capital Inc. headquartered?
Australis Capital Inc. is headquartered in United States.
Does AUSAF pay a dividend?
Australis Capital Inc. (AUSAF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AUSAF go public?
Australis Capital Inc. (AUSAF) completed its initial public offering in 2018.